ARCHIT ORGANOSYS LTD.

Archit Organosys Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code of conduct. The window will be shut from Wednesday, July 1, 2026, and will reopen 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. The specific date for the Board of Directors' meeting to approve these results will be intimated separately.

Archit Organosys Ltd approved the audited standalone financial results for the quarter and financial year ended March 31, 2026, in a board meeting held on May 16, 2026. The board also recommended a final dividend of ₹1 per equity share (10%) of ₹10 each for the financial year ended March 31, 2026. The auditor's report, issued by M/s G.K. Choksi & Co, Chartered Accountants, has an unmodified opinion on the standalone audited financial results.

The Board of Directors of Archit Organosys Ltd, in its meeting on May 16, 2026, approved the standalone audited financial results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of ₹1 per equity share (10%) of ₹10 each for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming AGM. The auditor's report issued by M/s G.K. Choksi & Co had an unmodified opinion on the standalone audited financial results.

Archit Organosys Ltd's Board of Directors approved the standalone audited financial results for the quarter and financial year ended March 31, 2026. The board also recommended a final dividend of ₹1 per equity share (10%) of ₹10 each for the financial year ended March 31, 2026. The auditor's report, issued by M/s G.K. Choksi & Co, Chartered Accountants, contains an unmodified opinion on the standalone audited financial results.

Archit Organosys Ltd has scheduled a Board of Directors meeting on May 16, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a final dividend for the year ended March 31, 2026, subject to shareholder approval. The trading window has been closed from April 1, 2026, and will reopen 48 hours after the results are made public.

Archit Organosys Ltd has scheduled a Board of Directors meeting on May 16, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. In compliance with SEBI regulations, the trading window for insiders has been closed from April 1, 2026, and will reopen 48 hours after the results are publicly available.

Archit Organosys Ltd received a clarification request from the Stock Exchange regarding significant movement in its share price. The company affirmed its compliance with SEBI (LODR) Regulations, 2015, stating it has promptly disclosed all material and price-sensitive information. It explicitly confirmed that there is no undisclosed price-sensitive information or any impending corporate action that could explain the recent price or volume behavior in its shares. The company attributed the share price fluctuations solely to market conditions, emphasizing that its management is not connected to these movements. Archit Organosys reiterated its commitment to continuous disclosures and compliance for investor interest.

Archit Organosys Ltd has announced the closure of the trading window for the quarter ended on 31.03.2026. The closure is in accordance with the Internal Code of Procedure and Conduct for Regulating, Monitoring and Reporting of Trading by insiders of the Company and SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed for Designated Persons and their Immediate relatives from Wednesday, 1st April, 2026, till 48 hours after the declaration of Audited Financial Results for the Quarter and Financial Year ended on 31st March, 2026. The date of the meeting of Board of Directors is yet to be intimated.

The Exchange has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Archit Organosys Ltd. The disclosure pertains to the acquisition of 19% equity shares of the company by Suchit Amin & PACs on 19th March, 2026. The total consideration for the acquisition is Rs. 20,52,07,230 consisting of 2,05,20,723 equity shares of Rs. 10/- each. The acquisition was made through the open market.

Archit Organosys Limited has executed a Banakhat for the purchase of land situated at Survey/Block No.: 41, Town: Kala Talav, District: Bhavnagar, from Shri Kandarp Krishnakant Amin, Chairman and Whole Time Director (Promoter) of the Company. The total consideration for the property is Rs. 10,51,00,000/- (Rupees Ten Crore Fifty-One Lakh Only). The necessary approvals from the Audit Committee and Board of Directors of the Company have been obtained. The Conveyance Deed/Sale Deed will be intimated to the Stock Exchange upon execution. Further details as required under SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 will be shared upon the execution of the Conveyance Deed.